Altogether, the T2DM models suggest that central obesity and dyslipidemia jointly contribute to reduced irisin levels, while the direct influence of insulin resistance markers diminishes when adiposity indices are considered. This evidence concerns the gene FNDC5 and metabolic syndrome.